BMS-066

Details

Stereochemistry	ACHIRAL
Molecular Formula	C19H21N7O2
Molecular Weight	379.4157
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

SMILES

CNC1=C2N=CN(C)C2=C3C=C(NC3=N1)C4=CC=CC(CNC(=O)COC)=N4

InChI

InChIKey=ULTCRVJUAZCGPP-UHFFFAOYSA-N

InChI=1S/C19H21N7O2/c1-20-19-16-17(26(2)10-22-16)12-7-14(24-18(12)25-19)13-6-4-5-11(23-13)8-21-15(27)9-28-3/h4-7,10H,8-9H2,1-3H3,(H,21,27)(H2,20,24,25)

HIDE SMILES / InChI

Approval Year

PubMed

Show entries

Title	Date	PubMed
Periodic, partial inhibition of IkappaB Kinase beta-mediated signaling yields therapeutic benefit in preclinical models of rheumatoid arthritis.	2009 Nov	19652024

Showing 1 to 1 of 1 entries

Previous1Next

Patents

Show entries

Name

Type

Language

BMS-066

Common Name

English

ACETAMIDE, N-((6-(1,5-DIHYDRO-1-METHYL-4-(METHYLAMINO)IMIDAZO(4,5-D)PYRROLO(2,3-B)PYRIDIN-7-YL)-2-PYRIDINYL)METHYL)-2-METHOXY-

Systematic Name

English

ACETAMIDE, N-((6-(1,6-DIHYDRO-1-METHYL-4-(METHYLAMINO)IMIDAZO(4,5-D)PYRROLO(2,3-B)PYRIDIN-7-YL)-2-PYRIDINYL)METHYL)-2-METHOXY-

Systematic Name

English

N-((6-(1,6-DIHYDRO-1-METHYL-4-(METHYLAMINO)IMIDAZO(4,5-D)PYRROLO(2,3-B)PYRIDIN-7-YL)-2-PYRIDINYL)METHYL)-2-METHOXYACETAMIDE

Systematic Name

English

Showing 1 to 4 of 4 entries

Previous1Next

Show entries

Code System

Code

Type

Description

FDA UNII

BL7XSD8R7B

PRIMARY

PUBCHEM

24825710

PRIMARY

CAS

914946-88-6

PRIMARY

Showing 1 to 3 of 3 entries

Previous1Next

ACTIVE MOIETY


					BL7XSD8R7B

BMS-066